Dr. Mazen Rajab
He possesses over 20 years of experience in the development of innovative pharmaceutical formulations, pharmaceutical nanotechnology, the design of new antimicrobial agents, as well as molecular modeling and pharmaceutical data analysis.
He worked at the Pharmacovigilance Center in Paris in collaboration with the World Health Organization and contributed to developing methods for assessing the causal relationship of adverse drug interactions. He also served as Production Manager at Pamela Pharmaceutical Industries in Damascus, where he led automation efforts and the development of new formulations. Since 2005, he has dedicated his efforts as a researcher at the Arab International University, leading projects in the use of nanotechnology for drug development, the design of innovative antibiotics, and conducting clinical and bioequivalence studies. In 2017, he assumed the position of Vice Dean for Scientific Affairs at the Faculty of Pharmacy of the university, combining academic management with applied research.
In addition to his practical expertise, he has a rich record of innovations; he obtained a European patent for an innovative metformin-based formulation for treating diabetes and a French patent for a multipurpose system for spectroscopic measurements using image analysis. He has also published numerous research papers in prestigious international scientific journals, covering a wide range of topics from pharmaceutical formulation development to toxicology and pharmacoepidemiology studies, as well as recent research on the COVID-19 vaccine and inflammatory factors among university students.
